Inbios International Inc
Innovative Diagnostics for Infectious Diseases
Seattle, United States · Founded 2015 · $20.8M raised
- Headquarters
- Seattle, Washington
- Employees
- 51–200
- Founded
- 2015
- Business Model
- B2B
- Website
- inbios.com
- Total Funding
- $20.8M
- Last Round
- $12.7M GrantNov 2022
About
InBios International specializes in the design, development, and manufacture of diagnostic assays for emerging infectious diseases and biothreats. Based in Seattle, Washington, the company offers immunodiagnostic products for diseases including dengue, chikungunya, West Nile virus, and Chagas disease. InBios is GMP compliant, FDA registered, USDA licensed, and ISO 13485:2016 certified.
Summary
Inbios International Inc is a Biotech company based in Seattle, United States, founded in 2015. It has raised $20.8M in total, most recently a $12.7M Grant round in Nov 2022.
Tech & App Stack
4 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Specialty pharmaceutical company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Biopharmaceutical services company
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/inbios-international-inc"><img src="https://indexed.vc/api/badge/company/inbios-international-inc" alt="Inbios International Inc on Indexed.vc" width="260" height="76" /></a>